Bowel Uptake on PET: — Normal, Inflammation, or Something to Follow Up

Not necessarily, and the report alone cannot tell you. Focal colonic uptake is a flag that warrants investigation, not a diagnosis. It means there is enough localised activity in one spot to look more closely — usually with a colonoscopy — to find out whether the cause is a polyp, an area of inflammation, or something that needs treatment. The only way to know is to examine that part of the bowel directly. Talk to your oncologist about the next step, which will be guided by your full clinical picture, not this one finding alone.

The most common causes are normal bowel muscle activity, mild generalised inflammation, and medication. Metformin, used by many people for diabetes, is one of the most well-recognised causes of diffuse FDG activity throughout the small and large bowel. The timing of the scan relative to your last meal and laxative preparations can also affect bowel activity. Diffuse uptake rarely requires further investigation unless your team has another clinical reason to examine the bowel.

Yes, and it is the appropriate next step when the PET report describes focal colonic uptake. A colonoscopy lets the gastroenterologist look directly at the area of concern, take a biopsy if anything is visible, and remove a polyp if one is found. It is the only test that can say definitively whether the uptake reflects normal tissue, a polyp, or something that needs treatment. Being referred does not mean your team is expecting the worst — it means they are not prepared to leave a finding uncharacterised.

Discuss this with your oncologist before deciding. Likely physiological is a probabilistic statement based on the pattern of the uptake, not a guarantee that nothing is there. For diffuse uptake this conclusion is well-supported. For a finding described as focal but attributed to physiology, it is reasonable to ask your treating team whether any follow-up is recommended — because missing an early lesion has real consequences and a colonoscopy is a straightforward investigation. A radiology report is not the final word on whether something needs action; that decision sits with your treating doctor.

It is possible, but not the most common explanation. When a known cancer spreads to the bowel it can cause focal FDG uptake — but so can a polyp, adenoma, or area of localised inflammation that has nothing to do with your primary cancer. Your oncologist will look at the CT images alongside the PET finding, consider your cancer type and its spread pattern, and decide whether the bowel finding fits metastatic disease or looks like a separate process. Tissue sampling is usually needed to answer the question definitively.

Yes. Small polyps and early lesions can show FDG activity without a visible change on the CT scan. This is one of the reasons PET-CT is read as a combined study — a focal hot spot on PET without a clear CT correlate is still significant. ESNM guidance recommends follow-up when focal colonic uptake is present regardless of whether there is a corresponding CT abnormality. Your radiologist and oncologist will weigh both components together when advising you on next steps.